Equities

Jin Medical International Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ZJYL:NAQ

Jin Medical International Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.14
  • Today's Change-0.007 / -4.44%
  • Shares traded179.67k
  • 1 Year change-83.63%
  • Beta--
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jin Medical International Ltd is a holding company mainly engaged in the design and manufacturing of wheelchairs. The Company, through its wholly owned subsidiaries, is primarily engaged in the design, development, manufacturing and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's wheelchair product category includes mid, high and low-end wheelchairs. The wheelchair components include wheels and brakes, which are sold to customers for after-sales service. The living aids product category consists of oxygen concentrators, bath aids and rehabilitative devices. The Company mainly distributes its products in domestic and overseas markets.

  • Revenue in USD (TTM)22.83m
  • Net income in USD1.79m
  • Incorporated2020
  • Employees269.00
  • Location
    Jin Medical International LtdNo. 33 Lingxiang Road, Wujin DistrictCHANGZHOU 213149ChinaCHN
  • Phone+86 51 989607972
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Phaos Technlgy Hldngs (Cayman) Limited132.98k-100.00bn14.53m--------109.26-------0.0605------------------------0.3176------------------
United Health Products Inc0.00-2.95m16.43m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Envoy Medical Inc208.00k-28.61m17.27m42.00------83.04-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
Retractable Technologies Inc37.90m-6.68m19.79m221.00--0.258523.800.5221-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Milestone Scientific Inc8.93m-6.67m20.76m17.00--8.14--2.32-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Adagio Medical Holdings Inc137.00k-79.15m20.86m86.00------152.28-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Inspira Technologies Oxy BHN Ltd289.00k-11.21m21.83m38.00--13.20--75.55-0.4606-0.46060.01280.04460.04170.52810.66597,605.26-161.61-109.16-302.02-145.380.692---3,879.24--0.9002--0.00------2.06--39.54--
Jin Medical International Ltd22.83m1.79m21.92m269.0012.230.785211.110.96010.01150.01150.14580.17830.5093.264.1584,857.363.8510.686.3416.5135.7934.537.5513.921.90--0.36170.0018.572.9027.710.155496.27--
IRIDEX Corp50.65m-5.09m23.72m93.00------0.4684-0.3026-0.30263.020.27461.733.437.74544,591.40-17.39-20.28-33.62-29.9638.1842.41-10.04-15.171.35--0.4418---6.172.306.90---36.71--
Global Innovative Platforms Inc0.00-718.26k23.84m52.00--120.87-----0.0179-0.01790.000.00420.00-------720.78---929.61--------------0.0079-------427.35------
PetVivo Holdings Inc1.41m-9.65m24.72m24.00--5.81--17.54-0.402-0.4020.05920.12690.33370.626110.3758,701.67-224.88-195.28-343.15-346.3378.8874.58-673.99-1,163.491.45-4.230.00--16.91216.0823.33--49.21--
Harvard Bioscience Inc87.37m-53.84m24.80m330.00--1.76--0.2839-1.22-1.221.980.31560.83521.587.01264,760.60-51.46-4.48-81.52-5.4756.9457.18-61.62-6.180.4081-0.56860.7071---16.14-4.12-263.25--21.83--
Wellgistics Health Inc34.08m-77.75m25.02m31.00--3.68--0.7341-1.32-1.320.61610.07580.6293.6317.53---143.52---365.21--7.86---228.17--0.1628-16.420.7854-------136.77------
Guided Therapeutics Inc178.00k-2.80m26.75m4.00------150.29-0.0386-0.03860.0025-0.06750.16540.108344.5044,500.00-244.61-129.80----62.9244.19-1,478.65-4,184.720.0334-4.13-----92.86-27.9331.07------
Baird Medical Investment Holdings Ltd31.86m-3.12m28.28m143.00--0.5745--0.8876-0.1128-0.11281.221.340.45523.270.8459222,797.30-4.48---7.64--86.94---9.84--1.67-0.3230.3856--17.74--18.57------
Data as of Feb 13 2026. Currency figures normalised to Jin Medical International Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Geode Capital Management LLCas of 31 Dec 2025106.54k0.07%
Jane Street Capital LLCas of 31 Dec 202550.92k0.03%
Renaissance Technologies LLCas of 31 Dec 202540.00k0.03%
Osaic Wealth, Inc. (Investment Management)as of 30 Sep 202523.00k0.02%
Millennium Management LLCas of 30 Sep 202519.57k0.01%
XTX Markets LLCas of 30 Sep 202517.78k0.01%
UBS Securities LLCas of 31 Dec 20254.49k0.00%
Bell Investment Advisors, Inc.as of 30 Sep 2025152.000.00%
Tower Research Capital LLCas of 30 Sep 2025100.000.00%
Morgan Stanley & Co. LLCas of 31 Dec 2025100.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.